Giovanni Paolino
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 260 publications
Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.
Journal: Italian journal of dermatology and venereology
Published: August 24, 2026
Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).
Journal: Dermatology and therapy
Published: July 14, 2026
Intradermal tranexamic acid and melasma: a systematic review and level of evidence.
Journal: Italian journal of dermatology and venereology
Published: May 21, 2026
Pregnancy and lactation during anifrolumab treatment in systemic lupus erythematosus.
Journal: Dermatology reports
Published: April 22, 2026
Sulforaphane as a Photoprotective Agent Against UV-Induced Skin Damage and Carcinogenesis: A Scoping Review.
Journal: Journal of personalized medicine
Published: April 21, 2026
Multiple primary and familial melanoma as distinct high-risk phenotypes: a retrospective cohort study.
Journal: Frontiers in genetics
Published: April 03, 2026
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).
Journal: Dermatology and therapy
Published: March 17, 2026
The relevance of membrane lipid composition in exosome-based precision dermatology.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 10, 2026
Widespread dermoscopic alterations of multiple melanocytic nevi in a patient receiving vandetanib: implications for dermatological surveillance.
Journal: Dermatology reports
Published: March 01, 2026
Targeting type I interferon in lupus panniculitis: a case-based systematic literature review.
Journal: Rheumatology international
Published: February 16, 2026
Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management.
Journal: Journal of clinical medicine
Published: January 29, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Last Updated: 09/26/2026